Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2024 of 6351
-
New hope: drug may shield brain from CAR T-Cell therapy side effects
Disease control Stopped earlyThis phase II trial studies how well anakinra works in preventing severe chimeric antigen receptor T-cell-related encephalopathy syndrome after chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma that has come back or has not responded to treatment. Im…
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can a cancer pill keep bone sarcomas at bay?
Disease control Recruiting nowRandomized, non-comparative, multicentre exploratory phase II study. Two arms concerning patients with bone sarcoma after the first line therapy: in the first arm, patients will be treated with Regorafenib for a maximum of 12 months as maintenance therapy after first line therap…
Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug shows promise for Long-Term control of ulcerative colitis
Disease control Stopped earlyThe purpose of this OLE Study D5272C00002 (Legacy #3151-202-008) is to permit participants who previously enrolled in the double-blind Study D5272C00001 (Legacy #3151-201-008) to receive brazikumab, allowing for long-term observation of safety and efficacy in these participants t…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Moms helping moms: peer program boosts HIV care after birth
Disease control CompletedThe purpose of this study is to test the efficacy of a theory-driven peer intervention for pregnant and postpartum women living HIV. The peer intervention is designed to increase self-efficacy, social support, self-regulatory behaviors, and outcome expectancy in order to improve …
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Week-Long heart patch could Out-Sleuth standard 24-Hour monitor for palpitations
Diagnosis Completed"This exploratory prospective clinical study aims to evaluate the diagnostic yield of a 7-day adhesive electrocardiographic (ECG) monitoring device (MEMO Patch) in detecting cardiac arrhythmias in patients presenting with palpitations. Participants who require 24-hour Holter mon…
Sponsor: HUINNO Co., Ltd • Aim: Diagnosis
Last updated Aug 01, 2026 00:00 UTC
-
Could a simple blood test spare thyroid cancer patients from unnecessary radiation?
Disease control Recruiting nowThis trial is comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy
Phase 3 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Pressing the right spots: could acupressure shield ears during oxygen therapy?
Symptom relief CompletedMiddle ear barotrauma (MEB) is the most common complication during hyperbaric oxygen therapy (HBOT). Though Valsalva and Toynbee maneuvers have been proposed to prevent MEB, still some patients discontinue HBOT due to severe otalgia, hemorrhage or perforation of tympanic membrane…
Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
New drug shows promise in preventing transplant complications
Disease control CompletedThis is a phase 2 open-label trial designed to evaluate the efficacy of tildrakizumab in improving graft-versus-host disease (GVHD)-free relapse-free survival after myeloablative allogeneic hematopoietic cell transplantation (alloHCT) for hematologic malignancy.
Phase 2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Oxygen chamber vs. pills: new hope for Trauma-Linked fibromyalgia?
Disease control CompletedThe investigators have previously studied the efficacy of hyperbaric oxygen therapy (HBOT) as a treatment for Fibromyalgia syndrome (FMS) in a prospective, active control, crossover clinical trial. The results demonstrated significant amelioration of all FMS symptoms, with signif…
Sponsor: Assaf-Harofeh Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Weight loss and walking: a new hope for PAD patients?
Disease control Recruiting nowThe PROVE Trial is a randomized clinical trial that will determine whether a weight loss intervention combined with walking exercise achieves greater improvement or less decline in six-minute walk distance at 12 month follow-up than walking exercise alone in people with PAD and B…
Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can a gentle air puff help preterm babies breathe and sleep better?
Symptom relief CompletedPilot study of 10 preterm, who are going to be randomly placed to 3 phases : 2 hour of basal observation of respiratory rate, heart rate, saturation, NIPS and aEEG recording, 2 hours with a 20cycles/minute with "scare ventilator", and 2 hours of 40 cycles/minute with "scare venti…
Sponsor: Pontificia Universidad Catolica de Chile • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Can light therapy unblock the gut without surgery?
Symptom relief CompletedAdhesive small bowel obstruction (ASBO) is one of the most common complications and is a major cause of admission after intra-abdominal surgery. To date, the ideal management of ASBO remains controversial. The aim of this protocol designed as a double-blind randomized controlled …
Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New radiation technique aims to protect lungs during stem cell transplants
Disease control OngoingThis trial studies how well radiation therapy techniques, volumetric modulated arc therapy (VMAT) and tomotherapy, work to reduce doses to the lung compared to standard total body irradiation methods to prevent pulmonary toxicities. Standard total body irradiation is limited in i…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Emotional stress may be a hidden trigger for repeat heart attacks — a study investigates
Knowledge-focused CompletedThe purpose of this study is to look at the link between emotional stress and heart disease in men and women. Taking part in this study involves one clinic visit, one week of at home monitoring, and follow up phone calls every 6 months for 3 years.
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
New daily HIV pill shows promise in landmark trial
Disease control CompletedThis is a phase 3, randomized, controlled, double-blind, multisite clinical study of a once-daily fixed dose combination (FDC) of 100 mg doravirine/0.75 mg islatravir (DOR/ISL \[also known as MK-8591A\]) in treatment-naïve participants living with human immunodeficiency virus typ…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Iron showdown: IV vs pills for anemia after gastric bypass
Disease control Recruiting nowGiven the limited long-term effectiveness of traditional weight loss methods, bariatric surgery is increasingly becoming the preferred option for sustained weight loss. With the ascendancy of the laparoscopic approach, the two most common procedures are the Roux-en-Y gastric bypa…
Phase 3 • Sponsor: Auerbach Hematology Oncology Associates P C • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Pee test could spot prostate cancer early
Diagnosis OngoingThe goal of this project is to detect prostate cancer cells, shed in voided urine, using the optical imaging method developed in our laboratory, which targets VPAC1 and STEAP1 receptors expressed on prostate cancer cells and validates the results with prevailing condition of the …
Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
Could less radiation be just as good for sarcoma?
Disease control OngoingThe investigators are doing this study to find out whether lowering the dose of postoperative radiation therapy and targeting a smaller area of tissue for treatment is as effective as the standard dose and volume of radiation therapy to control soft tissue sarcoma after surgery. …
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug may keep chemo on track for lung, ovarian, and breast cancer patients
Symptom relief OngoingTo evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or breast cancer measured by the ability to administer on-time, full-dose chemotherapy
Phase 3 • Sponsor: Amgen • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New coordinated care approach aims to boost stroke recovery
Disease control CompletedStroke is the 5th leading cause of death and the leading cause of adult disability in the United States (US). Stroke is a complex disease with multiple interacting risk factors (including genetic, high blood pressure and cholesterol, and lifestyle factors like smoking, diet, and …
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC